Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxidative Stress in Liver Pathophysiology and Disease. | Antioxidants (Basel) | 2023 | 37759956 | PubTator, text mining | PubMed |
| Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options. | Cells | 2023 | 37759536 | PubTator, text mining | PubMed |
| [Construction of Lung Adenocarcinoma Prognosis Model and Drug Sensitivity Analysis Based on Cuproptosis Related Genes]. | Zhongguo Fei Ai Za Zhi | 2023 | 37752539 | PubTator, text mining | PubMed |
| Inferring circadian gene regulatory relationships from gene expression data with a hybrid framework. | BMC Bioinformatics | 2023 | 37752445 | PubTator, text mining | PubMed |
| Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro. | Front Oncol | 2023 | 37746284 | PubTator, text mining | PubMed |
| Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease. | Pharmacol Ther | 2023 | 37741465 | PubTator, text mining | PubMed |
| ATP7B Gene Variant Profile İdentified by NGS in Wilson's Disease. | Fetal Pediatr Pathol | 2023 | 37737146 | PubTator, text mining | PubMed |
| Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug. | Redox Biol | 2023 | 37734229 | PubTator, text mining | PubMed |
| Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study. | Hum Genet | 2023 | 37728764 | PubTator, text mining | PubMed |
| Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma. | Aging (Albany NY) | 2023 | 37728407 | PubTator, text mining | PubMed |
| Wilson's Disease: A Prevalence Study in a Portuguese Population. | Cureus | 2023 | 37724235 | PubTator, text mining | PubMed |
| A focus groups study of staff team experiences of providing interdisciplinary rehabilitation for people with dementia and their caregivers-a co-creative journey. | BMC Geriatr | 2023 | 37723442 | PubTator, text mining | PubMed |
| Cognitive and gait in Wilson's disease: a cognitive and motor dual-task study. | Front Neurol | 2023 | 37719756 | PubTator, text mining | PubMed |
| ATP7B R778L mutant hepatocytes resist copper toxicity by activating autophagy and inhibiting necroptosis. | Cell Death Discov | 2023 | 37717021 | PubTator, text mining | PubMed |
| Genome editing without nucleases confers proliferative advantage to edited hepatocytes and corrects Wilson disease. | JCI Insight | 2023 | 37707949 | PubTator, text mining | PubMed |
| Hepatitis B virus infection in patients with Wilson disease: A large retrospective study. | World J Gastroenterol | 2023 | 37701133 | PubTator, text mining | PubMed |
| Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma. | Transl Cancer Res | 2023 | 37701111 | PubTator, text mining | PubMed |
| Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma. | J Otolaryngol Head Neck Surg | 2023 | 37697421 | PubTator, text mining | PubMed |
| Metabolomic profiling of Wilson disease, an inherited disorder of copper metabolism, and diseases with similar symptoms but normal copper metabolism. | Orphanet J Rare Dis | 2023 | 37697371 | PubTator, text mining | PubMed |
| The role of intestine in metabolic dysregulation in murine Wilson disease. | Hepatol Commun | 2023 | 37695076 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=25